Memory impairment and neural dysfunction after continuous infusion of anti-nerve growth factor antibody into the septum in adult rats

A. Nitta, K. Murase, Y. Furukawa, K. Hayashi, T. Hasegawa, T. Nabeshima

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Nerve growth factor is required for the survival and maintenance of cholinergic neurons in the central nervous system.9,15 The direct infusion into the rat's septum of an anti-nerve growth factor monoclonal antibody, which inhibits nerve growth factor bioactivity seven times more strongly than a polyclonal antibody, caused very severe damage to the hippocampal cholinergic system. Anti-nerve growth factor polyclonal antibody also neutralized endogenously occurring nerve growth factor. The infusion of anti-nerve growth factor polyclonal antibody produced a dysfunction of memory and decreased choline acetyltransferase activity and acetylcholinesterase staining in the hippocampus. The cholinergic dysfunction and impairment of memory recovered to the normal level two weeks after cessation of the infusion of the anti-nerve growth factor polyclonal antibody. These results suggest that a deficit of nerve growth factor in the adult brain causes neuronal dysfunction.

Original languageEnglish
Pages (from-to)495-499
Number of pages5
JournalNeuroscience
Volume57
Issue number3
DOIs
Publication statusPublished - 12-1993

Fingerprint

Nerve Growth Factor
Antibodies
Cholinergic Agents
Cholinergic Neurons
Choline O-Acetyltransferase
Acetylcholinesterase
Hippocampus
Monoclonal Antibodies
Maintenance
Staining and Labeling
Brain

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Nitta, A. ; Murase, K. ; Furukawa, Y. ; Hayashi, K. ; Hasegawa, T. ; Nabeshima, T. / Memory impairment and neural dysfunction after continuous infusion of anti-nerve growth factor antibody into the septum in adult rats. In: Neuroscience. 1993 ; Vol. 57, No. 3. pp. 495-499.
@article{fde64b35139b42ad91b5ba2fb02e4b29,
title = "Memory impairment and neural dysfunction after continuous infusion of anti-nerve growth factor antibody into the septum in adult rats",
abstract = "Nerve growth factor is required for the survival and maintenance of cholinergic neurons in the central nervous system.9,15 The direct infusion into the rat's septum of an anti-nerve growth factor monoclonal antibody, which inhibits nerve growth factor bioactivity seven times more strongly than a polyclonal antibody, caused very severe damage to the hippocampal cholinergic system. Anti-nerve growth factor polyclonal antibody also neutralized endogenously occurring nerve growth factor. The infusion of anti-nerve growth factor polyclonal antibody produced a dysfunction of memory and decreased choline acetyltransferase activity and acetylcholinesterase staining in the hippocampus. The cholinergic dysfunction and impairment of memory recovered to the normal level two weeks after cessation of the infusion of the anti-nerve growth factor polyclonal antibody. These results suggest that a deficit of nerve growth factor in the adult brain causes neuronal dysfunction.",
author = "A. Nitta and K. Murase and Y. Furukawa and K. Hayashi and T. Hasegawa and T. Nabeshima",
year = "1993",
month = "12",
doi = "10.1016/0306-4522(93)90001-V",
language = "English",
volume = "57",
pages = "495--499",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "3",

}

Memory impairment and neural dysfunction after continuous infusion of anti-nerve growth factor antibody into the septum in adult rats. / Nitta, A.; Murase, K.; Furukawa, Y.; Hayashi, K.; Hasegawa, T.; Nabeshima, T.

In: Neuroscience, Vol. 57, No. 3, 12.1993, p. 495-499.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Memory impairment and neural dysfunction after continuous infusion of anti-nerve growth factor antibody into the septum in adult rats

AU - Nitta, A.

AU - Murase, K.

AU - Furukawa, Y.

AU - Hayashi, K.

AU - Hasegawa, T.

AU - Nabeshima, T.

PY - 1993/12

Y1 - 1993/12

N2 - Nerve growth factor is required for the survival and maintenance of cholinergic neurons in the central nervous system.9,15 The direct infusion into the rat's septum of an anti-nerve growth factor monoclonal antibody, which inhibits nerve growth factor bioactivity seven times more strongly than a polyclonal antibody, caused very severe damage to the hippocampal cholinergic system. Anti-nerve growth factor polyclonal antibody also neutralized endogenously occurring nerve growth factor. The infusion of anti-nerve growth factor polyclonal antibody produced a dysfunction of memory and decreased choline acetyltransferase activity and acetylcholinesterase staining in the hippocampus. The cholinergic dysfunction and impairment of memory recovered to the normal level two weeks after cessation of the infusion of the anti-nerve growth factor polyclonal antibody. These results suggest that a deficit of nerve growth factor in the adult brain causes neuronal dysfunction.

AB - Nerve growth factor is required for the survival and maintenance of cholinergic neurons in the central nervous system.9,15 The direct infusion into the rat's septum of an anti-nerve growth factor monoclonal antibody, which inhibits nerve growth factor bioactivity seven times more strongly than a polyclonal antibody, caused very severe damage to the hippocampal cholinergic system. Anti-nerve growth factor polyclonal antibody also neutralized endogenously occurring nerve growth factor. The infusion of anti-nerve growth factor polyclonal antibody produced a dysfunction of memory and decreased choline acetyltransferase activity and acetylcholinesterase staining in the hippocampus. The cholinergic dysfunction and impairment of memory recovered to the normal level two weeks after cessation of the infusion of the anti-nerve growth factor polyclonal antibody. These results suggest that a deficit of nerve growth factor in the adult brain causes neuronal dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=0027427528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027427528&partnerID=8YFLogxK

U2 - 10.1016/0306-4522(93)90001-V

DO - 10.1016/0306-4522(93)90001-V

M3 - Article

C2 - 7508574

AN - SCOPUS:0027427528

VL - 57

SP - 495

EP - 499

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 3

ER -